Sandra Nichols, PHD, APRN, PMHNP-BC,
NPI: 1770749202
Total Payments
$4,063
2024 Payments
$883.13
Companies
19
Transactions
173
Medicare Patients
386
Medicare Billing
$42,512
Payment Breakdown by Category
Food & Beverage$4,063 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,063 | 173 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,096 | 42 | $0 (2024) |
| ABBVIE INC. | $893.79 | 53 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $673.47 | 26 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $307.87 | 10 | $0 (2024) |
| EISAI INC. | $188.52 | 2 | $0 (2022) |
| Corium, LLC | $156.53 | 8 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $136.52 | 8 | $0 (2024) |
| Sage Therapeutics, Inc. | $106.50 | 1 | $0 (2023) |
| Lundbeck LLC | $99.61 | 5 | $0 (2024) |
| ITI, Inc. | $79.81 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $883.13 | 36 | Otsuka America Pharmaceutical, Inc. ($306.86) |
| 2023 | $1,628 | 75 | Otsuka America Pharmaceutical, Inc. ($523.13) |
| 2022 | $1,269 | 54 | Otsuka America Pharmaceutical, Inc. ($265.89) |
| 2021 | $282.82 | 8 | AbbVie Inc. ($282.82) |
All Payment Transactions
173 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Neuropsychiatry | ||||||
| 10/24/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Obesity | ||||||
| 10/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/23/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: PSYCHIATRY | ||||||
| 08/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: PSYCHIATRY | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $117.04 | General |
| Category: PSYCHIATRY | ||||||
| 06/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PSYCHIATRY | ||||||
| 06/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $47.36 | General |
| Category: PSYCHIATRY | ||||||
| 06/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Neuroscience | ||||||
| 05/28/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.54 | General |
| Category: PSYCHIATRY | ||||||
| 05/13/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: PSYCHIATRY | ||||||
| 05/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE | ||||||
| 05/01/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: OUD | ||||||
| 04/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.54 | General |
| Category: NEUROSCIENCE | ||||||
| 04/17/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: Neuropsychiatry | ||||||
| 04/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Neuroscience | ||||||
| 03/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $99.31 | General |
| Category: Neuropsychiatry | ||||||
| 03/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 103 | 284 | $38,470 | $12,789 |
| 2022 | 4 | 67 | 153 | $27,248 | $7,842 |
| 2021 | 3 | 59 | 112 | $77,707 | $7,408 |
| 2020 | 4 | 157 | 166 | $245,531 | $14,473 |
Total Patients
386
Total Services
715
Medicare Billing
$42,512
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 80 | $10,560 | $3,558 | 33.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 44 | $9,000 | $3,135 | 34.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 33 | 86 | $8,428 | $2,738 | 32.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 21 | 35 | $6,370 | $1,765 | 27.7% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 17 | 39 | $4,112 | $1,593 | 38.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 30 | 84 | $15,288 | $3,948 | 25.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 24 | $3,646 | $1,731 | 47.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 16 | $5,472 | $1,426 | 26.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 12 | 29 | $2,842 | $736.91 | 25.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 77 | $14,014 | $3,753 | 26.8% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 21 | 21 | $43,869 | $2,652 | 6.0% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 14 | 14 | $19,824 | $1,003 | 5.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 71 | 75 | $135,838 | $7,716 | 5.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 53 | 55 | $64,694 | $3,937 | 6.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 13 | 13 | $29,812 | $1,908 | 6.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 20 | 23 | $15,187 | $911.54 | 6.0% |
About Sandra Nichols, PHD, APRN, PMHNP-BC,
Sandra Nichols, PHD, APRN, PMHNP-BC, is a Psychiatric/Mental Health healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/04/2008. The National Provider Identifier (NPI) number assigned to this provider is 1770749202.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sandra Nichols, PHD, APRN, PMHNP-BC, has received a total of $4,063 in payments from pharmaceutical and medical device companies, with $883.13 received in 2024. These payments were reported across 173 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,063).
As a Medicare-enrolled provider, Nichols has provided services to 386 Medicare beneficiaries, totaling 715 services with total Medicare billing of $42,512. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatric/Mental Health
- Other Specialties Psychiatric/Mental Health, Family
- Location Virginia Beach, VA
- Active Since 08/04/2008
- Last Updated 01/16/2026
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1770749202
Products in Payments
- VRAYLAR (Drug) $893.79
- REXULTI (Drug) $769.94
- SPRAVATO (Drug) $652.48
- ABILIFY MAINTENA (Drug) $375.23
- INGREZZA (Drug) $307.87
- Lenvima (Drug) $188.52
- CAPLYTA (Drug) $141.68
- TRINTELLIX (Drug) $115.13
- Azstarys (Drug) $107.00
- ABILIFY ASIMTUFII (Drug) $50.32
- AZSTARYS (Drug) $49.53
- ARISTADA (Drug) $49.26
- Wegovy (Drug) $33.78
- Nuedexta (Drug) $28.33
- Dyanavel XR (Drug) $22.57
- ENTYVIO (Biological) $21.39
- INVEGA SUSTENNA (Drug) $20.99
- Austedo XR (Drug) $19.58
- SUBLOCADE (Drug) $15.91
- Adzenys XR-ODT (Drug) $14.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Virginia Beach
Genise Binns
Psychiatric/Mental Health — Payments: $10,066
Psychiatric/Mental Health $10,066
Mrs. Nakeshia Mouzon, Fnp, Pmhnp, FNP, PMHNP
Psychiatric/Mental Health — Payments: $6,575
Psychiatric/Mental Health $6,575
Mary Crutchfield, Pmhnp, Fnp, PMHNP, FNP
Psychiatric/Mental Health — Payments: $6,091
Psychiatric/Mental Health $6,091
Mrs. Arnella Edwards
Psychiatric/Mental Health — Payments: $5,663
Psychiatric/Mental Health $5,663
Jamie Deputy, Msn, Aprn, Pmhnp-Bc, MSN, APRN, PMHNP-BC
Psychiatric/Mental Health — Payments: $4,582
Psychiatric/Mental Health $4,582
Brittany Smith, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $4,301
Psychiatric/Mental Health $4,301